To the Editor: The genomic landscape of lower-grade gliomas has recently been investigated in “multi-omic” analyses that have revealed molecular subgroups with prognostic relevance. In particular, robust biomarkers, including 1p/19q codeletion (deletion of chromosome arms 1p and 19q), IDH mutation,…
Read More...…
Read More...